BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,569 | -43.2% | 14,484 | 0.0% | 0.00% | – |
| Q2 2023 | $73,144 | +62.5% | 14,484 | -19.5% | 0.00% | – |
| Q2 2022 | $45,000 | -66.4% | 17,994 | -62.7% | 0.00% | – |
| Q1 2022 | $134,000 | -58.4% | 48,287 | -19.9% | 0.00% | – |
| Q4 2021 | $322,000 | -37.0% | 60,313 | 0.0% | 0.00% | – |
| Q3 2021 | $511,000 | -64.7% | 60,313 | -49.1% | 0.00% | – |
| Q2 2021 | $1,446,000 | -47.9% | 118,583 | +3.6% | 0.00% | -100.0% |
| Q1 2021 | $2,778,000 | -19.8% | 114,506 | +5.9% | 0.00% | 0.0% |
| Q4 2020 | $3,466,000 | +7.6% | 108,127 | +1.5% | 0.00% | 0.0% |
| Q3 2020 | $3,222,000 | -6.0% | 106,569 | +31.2% | 0.00% | -50.0% |
| Q2 2020 | $3,426,000 | +437.0% | 81,255 | +218.0% | 0.00% | – |
| Q1 2020 | $638,000 | – | 25,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $5,830,000 | 0.29% |
| K2 PRINCIPAL FUND, L.P. | 1,031,511 | $1,743,000 | 0.20% |
| Boxer Capital, LLC | 2,014,858 | $3,405,000 | 0.19% |
| DAFNA Capital Management LLC | 313,600 | $530,000 | 0.14% |
| Newtyn Management, LLC | 350,000 | $592,000 | 0.13% |
| Artal Group S.A. | 1,646,517 | $2,783,000 | 0.12% |
| Bellevue Group AG | 4,717,113 | $7,972,000 | 0.11% |
| MPM BioImpact LLC | 239,888 | $405,000 | 0.10% |
| RA Capital Management | 2,589,904 | $4,377,000 | 0.09% |
| Beacon Capital Management, LLC | 35,615 | $88,000 | 0.03% |